With growing complexity of post-marketing requirements and commitments in oncology putting strain on the already stretched clinical research ecosystem, pragmatic research is well suited to bridge the gap between care and research.
In this webinar, experts from The Reagan-Udall Foundation for the FDA, Flatiron Health, and Johnson & Johnson:
- Highlight the value of post-marketing studies and key frameworks for efficient and impactful evidence generation
- Present an overview of PMR/PMCs in oncology and opportunities for real-world evidence generation approaches
- Share examples of more pragmatic approaches to PMR/PMCs
Learn more about our evidence solutions
